2021 annual financial data
Tango Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -160.7%.
Operating income was -58,190,000 USD and net income was -58,235,000 USD.
Operating cash flow was -59,527,000 USD.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,042,000 USD
- Operating income
- -58,190,000 USD
- Net income
- -58,235,000 USD
- Operating cash flow
- -59,527,000 USD